NovaBridge Biosciences (NASDAQ: IMAB)

Some price data may be temporarily unavailable.

KEY DATA POINTS

Current Price

N/A

Daily Change

N/A

Day's Range

N/A

Previous Close

N/A

Open

N/A

Beta

N/A

Volume

N/A

Average Volume

N/A

Sector

Health Care

Market Cap

N/A

Market Cap / Employee

N/A

52wk Range

N/A

Revenue

N/A

Gross Margin

N/A

Dividend Yield

N/A

EPS

N/A

CAPs Rating

N/A

Industry

Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

NovaBridge Biosciences Company Info

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Pudong, China.